CME Group Files 8-K on Officer/Director Changes & Compensation

Ticker: CME · Form: 8-K · Filed: 2024-11-07T00:00:00.000Z

Sentiment: neutral

Topics: corporate-governance, officer-changes, compensation

Related Tickers: CME

TL;DR

CME Group 8-K: Director/officer changes, appointments, and compensation details filed Nov 7.

AI Summary

CME Group Inc. filed an 8-K on November 7, 2024, reporting on events that occurred on November 6, 2024. The filing includes information regarding the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. It also covers Regulation FD disclosures and financial statements and exhibits.

Why It Matters

This filing provides crucial updates on the leadership and compensation structure of CME Group, which can impact investor confidence and strategic direction.

Risk Assessment

Risk Level: low — The filing is routine corporate disclosure and does not indicate any immediate financial distress or significant negative events.

Key Numbers

Key Players & Entities

FAQ

What specific officer or director positions were affected by the events reported on November 6, 2024?

The filing indicates changes related to 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers,' but the specific names and roles are detailed within the full report, not summarized in the header.

Are there any new compensatory arrangements for officers detailed in this filing?

Yes, the filing explicitly mentions 'Compensatory Arrangements of Certain Officers' as an item of information being reported.

Does this 8-K filing include any new financial statements?

Yes, the filing lists 'Financial Statements and Exhibits' as an item of information being reported.

What is the significance of the 'Regulation FD Disclosure' item?

This indicates that the company is making disclosures that could be of interest to investors, ensuring fair and broad dissemination of material information.

When was CME Group Inc. previously known as Chicago Mercantile Exchange Holdings Inc.?

The date of the name change from Chicago Mercantile Exchange Holdings Inc. to CME Group Inc. was August 2, 2001.

From the Filing

0001193125-24-252912.txt : 20241107 0001193125-24-252912.hdr.sgml : 20241107 20241107131959 ACCESSION NUMBER: 0001193125-24-252912 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20241106 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20241107 DATE AS OF CHANGE: 20241107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CME GROUP INC. CENTRAL INDEX KEY: 0001156375 STANDARD INDUSTRIAL CLASSIFICATION: SECURITY & COMMODITY BROKERS, DEALERS, EXCHANGES & SERVICES [6200] ORGANIZATION NAME: 02 Finance IRS NUMBER: 364459170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31553 FILM NUMBER: 241434454 BUSINESS ADDRESS: STREET 1: 20 S. WACKER DR. CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 3129301000 MAIL ADDRESS: STREET 1: 20 S. WACKER DR. CITY: CHICAGO STATE: IL ZIP: 60606 FORMER COMPANY: FORMER CONFORMED NAME: CHICAGO MERCANTILE EXCHANGE HOLDINGS INC DATE OF NAME CHANGE: 20010802 8-K 1 d859792d8k.htm 8-K 8-K false 0001156375 0001156375 2024-11-06 2024-11-06     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549     FORM 8-K     CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) November 7, 2024 ( November 6, 2024 )     CME GROUP INC. (Exact Name of Registrant as Specified in its Charter)       Delaware   001-31553   36-4459170 (State or Other Jurisdiction of Incorporation)   (Commission File No.)   (IRS Employer Identification No.)   20 South Wacker Drive   Chicago   Illinois   60606 (Address of Principal Executive Offices)       (Zip Code) Registrant’s telephone number, including area code: (312) 930-1000 N/A (Former Name or Former Address, if Changed Since Last Report)     Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading symbol   Name of each exchange on which registered Class A Common Stock   CME   Nasdaq Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) of this chapter or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company  ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.       Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. As described in the attached press release, on November 6, 2024, the Board of Directors (the “Board”) of CME Group Inc. (“CME Group” or the “Company”), based on the recommendations of the Nominating and G

View on Read The Filing